Home › Funds › Grantham, Mayo, Van Otterloo & Co. LLC › MRK

Grantham, Mayo, Van Otterloo & Co. LLC position in MRK

MERCK & CO · Health Care

Grantham, Mayo, Van Otterloo & Co. LLC reported holding 5,020,532 shares of MRK (MERCK & CO) in its Q3 2026 13F filing — a position valued at US$729.5M, representing 1.57% of its reported portfolio and ranking #19 among its reported holdings. Grantham, Mayo, Van Otterloo & Co. LLC has disclosed MRK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)5.02M sh
Reported value held$729.53M
Portfolio Weight1.57%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Grantham, Mayo, Van Otterloo & Co. LLC's MRK position evolved

Grantham, Mayo, Van Otterloo & Co. LLC first disclosed a stake in MRK in Q3 2023 at 4,028,916 shares (US$414.8M). The position peaked in Q2 2026 at 6,785,008 shares, worth US$871.9M. Across 13 filings, Grantham, Mayo, Van Otterloo & Co. LLC increased the stake 8 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 5,020,532 shares valued at US$729.5M — a reduction of -1,764,476 shares quarter over quarter.. Notable position changes include a 26% trim in Q3 2026 (shares rose 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 4.03M $414.78M New
Q4 2023 4.03M $438.90M Hold
Q1 2024 4.73M $623.74M Add
Q2 2024 5.33M $659.64M Add
Q3 2024 5.91M $671.37M Add
Q4 2024 6.17M $613.32M Add
Q1 2025 6.69M $600.19M Add
Q2 2025 6.47M $512.13M Reduce
Q3 2025 6.63M $556.07M Add
Q4 2025 6.87M $723.15M Add
Q1 2026 7.01M $843.69M Add
Q2 2026 6.79M $871.87M Reduce
Q3 2026 5.02M $729.53M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MRK and 13F data

MRK (MERCK & CO) is a Health Care company. 30 other funds we track also report a position in MRK — the largest reported positions include BlackRock Inc (US$29.17B), Vanguard Group (US$26.77B), VANGUARD CAPITAL MANAGEMENT LLC (US$23.47B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MRK

All MRK fund holders →

FAQ

How long has Grantham, Mayo, Van Otterloo & Co. LLC held MRK?

Grantham, Mayo, Van Otterloo & Co. LLC has disclosed MRK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Grantham, Mayo, Van Otterloo & Co. LLC's current position in MRK?

As of Q3 2026, Grantham, Mayo, Van Otterloo & Co. LLC holds 5.02M shares of MRK (MERCK & CO), valued at $729.53M, representing 1.57% of its reported portfolio and ranking #19.

Has Grantham, Mayo, Van Otterloo & Co. LLC been buying or selling MRK?

In the latest 13F filing (Q3 2026), Grantham, Mayo, Van Otterloo & Co. LLC reduced its position in MRK. The position peaked in Q2 2026 at 6.79M shares.

Which other funds hold MRK?

Other major institutional holders of MRK include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.